Identification and management of patients at elevated cardiometabolic risk in Canadian primary care: How well are we doing?

Canadian Journal of Cardiology

Volumn 29, Issue 8, 2013, Pages 960-968

  Teoh, Hwee ^a   Després, Jean Pierre ^b   Dufour, Robert ^c   Fitchett, David H ^a,d   Goldin, Lianne ^e   Goodman, Shaun G ^a,d,e   Harris, Stewart B ^f   Langer, Anatoly ^a,d,e   Lau, David C W ^g   Lonn, Eva M ^h   John Mancini, G B ⁱ   McFarlane, Philip A ^a,d   Poirier, Paul ^b,j   Rabasa Lhoret, Rémi ^c   Tan, Mary K ^e   Leiter, Lawrence A ^a,d,k  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e CANADIAN HEART RESEARCH CENTRE   (Canada)

^f WESTERN UNIVERSITY   (Canada)

^g UNIVERSITY OF CALGARY   (Canada)

^h MCMASTER UNIVERSITY   (Canada)

ⁱ UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^j LAVAL UNIVERSITY   (Canada)

^k UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; CARDIOMETABOLIC RISK; DYSLIPIDEMIA; FEMALE; FRAMINGHAM RISK SCORE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICIAN; PRIMARY MEDICAL CARE; RISK ASSESSMENT; WAIST CIRCUMFERENCE;

ADULT; AGED; BODY MASS INDEX; CANADA; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; RISK ASSESSMENT; RISK FACTORS;

EID: 84881026198     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2012.12.001     Document Type: Article

References (41)

1. Leiter L.A., Fitchett D.H., Gilbert R.E., et al. Identification and management of cardiometabolic risk in Canada: a position paper by the cardiometabolic risk working group (executive summary). Can J Cardiol 2011, 27:124-131.
2. Leiter L.A., Fitchett D.H., Gilbert R.E., et al. Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group. Can J Cardiol 2011, 27:e1-33.
3. Canadian Diabetes Association 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008, 32:S1-201. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee.
4. Genest J., McPherson R., Frohlich J., et al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. Can J Cardiol 2009, 25:567-579.
5. Daskalopoulou S.S., Khan N.A., Quinn R.R., et al. The 2012 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol 2012, 28:270-287.
6. Tobe S.W., Stone J.A., Brouwers M., Bhattacharyya O., Walker K.M., Dawes M., et al. Harmonization of guidelines for the prevention and treatment of cardiovascular disease: the C-CHANGE Initiative. CMAJ 2011, 183:E1135-E1150.
7. Lau D.C., Douketis J.D., Morrison K.M., Hramiak I.M., Sharma A.M., Ur E. 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children (summary). CMAJ 2007, 176:S1-13.
8. D'Agostino R.B., Vasan R.S., Pencina M.J., et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008, 117:743-753.
9. Health Canada Canadian Guidelines for Body Weight Classification in Adults 2003, Health Canada, Ottawa, Ontario.
10. Alberti K.G., Eckel R.H., Grundy S.M., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645.
11. Mottillo S., Filion K.B., Genest J., et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. JAm Coll Cardiol 2010, 56:1113-1132.
12. Gami A.S., Witt B.J., Howard D.E., et al. Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. JAm Coll Cardiol 2007, 49:403-414.
13. World Health Organization. Obesity and overweight. Geneva, Switzerland: World Health Organization, 2012. Available at: Accessed June 22, 2012. http://www.who.int/mediacentre/factsheets/fs311/en/.
14. Lavie C.J., Milani R.V., Ventura H.O. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. JAm Coll Cardiol 2009, 53:1925-1932.
15. International Diabetes Federation. IDF Diabetes Atlas, 5th ed. Brussels, Belgium: International Diabetes Federation, 2011. Available at: Accessed February 7, 2013. http://www.idf.org/diabetesatlas.
16. Obesity in Canada 2011, The Public Health Agency of Canada and the Canadian Institute for Health Information, The Public Health Agency of Canada and the Canadian Institute for Health Information, Ottawa.
17. The top 10 causes of death 2008, World Health Organization, World Health Organization, Geneve.
18. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364:937-952.
19. Ma J., Xiao L., Stafford R.S. Adult obesity and office-based quality of care in the United States. Obesity (Silver Spring) 2009, 17:1077-1085.
20. Smith S.C., Haslam D. Abdominal obesity, waist circumference and cardio-metabolic risk: awareness among primary care physicians, the general population and patients at risk-the Shape of the Nations survey. Curr Med Res Opin 2007, 23:29-47.
21. Cornier M.A., Despres J.P., Davis N., et al. Assessing adiposity: a scientific statement from the American Heart Association. Circulation 2011, 124:1996-2019.
22. Said Q., Marx C.M., Schwartz J.S., Ben-Joseph R., Brixner D.I. Impact of body mass index on the incidence of cardiometabolic risk factors in ambulatory care settings over 5 years or more. Value Health 2010, 13:265-272.
23. Wilson P.W., D'Agostino R.B., Sullivan L., Parise H., Kannel W.B. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002, 162:1867-1872.
24. Ghandehari H., Le V., Kamal-Bahl S., Bassin S.L., Wong N.D. Abdominal obesity and the spectrum of global cardiometabolic risks in US adults. Int J Obes (Lond) 2009, 33:239-248.
25. Screening for and Management of Obesity in Adults: US Preventive Services Task Force Recommendation. Ann Intern Med 2012, 157:373-378. US Preventive Services Task Force.
26. Hu F.B. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care 2011, 34:1249-1257.
27. Cornelissen V.A., Fagard R.H., Coeckelberghs E., Vanhees L. Impact of resistance training on blood pressure and other cardiovascular risk factors: a meta-analysis of randomized, controlled trials. Hypertension 2011, 58:950-958.
28. Grundy S.M., Barlow C.E., Farrell S.W., Vega G.L., Haskell W.L. Cardiorespiratory fitness and metabolic risk. Am J Cardiol 2012, 109:988-993.
29. Ilanne-Parikka P., Laaksonen D.E., Eriksson J.G., et al. Leisure-time physical activity and the metabolic syndrome in the Finnish diabetes prevention study. Diabetes Care 2010, 33:1610-1617.
30. Kastorini C.M., Milionis H.J., Esposito K., Giugliano D., Goudevenos J.A., Panagiotakos D.B. The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. JAm Coll Cardiol 2011, 57:1299-1313.
31. Pegklidou K., Nicolaou I., Demopoulos V.J. Nutritional overview on the management of type 2 diabetes and the prevention of its complications. Curr Diabetes Rev 2010, 6:400-409.
32. Malik V.S., Popkin B.M., Bray G.A., Despres J.P., Hu F.B. Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation 2010, 121:1356-1364.
33. Dale K.S., McAuley K.A., Taylor R.W., et al. Determining optimal approaches for weight maintenance: a randomized controlled trial. CMAJ 2009, 180:E39-E46.
34. Lawton B.A., Rose S.B., Elley C.R., Dowell A.C., Fenton A., Moyes S.A. Exercise on prescription for women aged 40-74 recruited through primary care: two year randomised controlled trial. BMJ 2008, 337:a2509.
35. Braga M., Casanova A., Teoh H., et al. Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada. Can J Cardiol 2010, 26:297-302.
36. Braga M.F., Casanova A., Teoh H., et al. Poor achievement of guidelines-recommended targets in type 2 diabetes: findings from a contemporary prospective cohort study. Int J Clin Pract 2012, 66:457-464.
37. Teoh H., Braga M.F., Casanova A., et al. Patient age, ethnicity, medical history, and risk factor profile, but not drug insurance coverage, predict successful attainment of glycemic targets: Time 2 Do More Quality Enhancement Research Initiative (T2DM QUERI). Diabetes Care 2010, 33:2558-2560.
38. Acharjee S., Cannon C.P. Office-based global cardiometabolic risk assessment: a simple tool incorporating nontraditional markers. Crit Pathw Cardiol 2010, 9:156-159.
39. Gilfillan R.J., Tomcavage J., Rosenthal M.B., et al. Value and the medical home: effects of transformed primary care. Am J Manag Care 2010, 16:607-614.
40. Thind A., Feightner J., Stewart M., Thorpe C., Burt A. Who delivers preventive care as recommended? Analysis of physician and practice characteristics. Can Fam Physician 2008, 54:1574-1575.
41. Kiran T., Victor J.C., Kopp A., Shah B.R., Glazier R.H. The relationship between financial incentives and quality of diabetes care in Ontario, Canada. Diabetes Care 2012, 35:1038-1046.